US-based company using next-generation Blow-Fill-Seal equipment and prefabricated robotic packaging lines to fill-finish generic injectable medicines. Operational subsidiary of ApiJect. Two business approaches: (1) producing compounded pharmaceutical products for the US market through its Global Pharmacy Reserve division, and (2) licensing prefabricated fill-finish lines with their technology to pharma companies globally (Pharmaceutical Reserve Network). Focused on addressing drug shortages of generic injectables. Headquartered in Stamford, CT with operations in Newtown, PA. FDA-registered with 1 NAI inspection.
Blow-Fill-Seal (BFS) sterile fill-finish technology, generic injectable manufacturing, drug shortage compounding, prefabricated modular fill-finish line licensing, affordable generic injectable production.
1 site worldwide
No reviews available yet.
No documents available.